Gabelli Funds LLC Neogenomics Inc Transaction History

Gabelli Funds LLC

$12.3 Billion
Q4 2024

A detailed history of Gabelli Funds LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Gabelli Funds LLC holds 14,000 shares of NEO stock, worth $155,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,000

Previous 18,000 22.22%

Holding current value

$155,400

Previous $265,000 13.21%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$13.0 - $18.43 $52,000 - $73,720	-4,000 Reduced 22.22%	14,000 $230,000
Q1 2024 May 14, 2024	BUY	$14.06 - $16.79 $253,080 - $302,220	18,000 New	18,000 $282,000
Q3 2022 Nov 10, 2022	SELL	$7.86 - $12.91 $157,200 - $258,200	-20,000 Reduced 41.67%	28,000 $241,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $4,942 - $9,779	-700 Reduced 1.44%	48,000 $391,000
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $48,600 - $141,120	4,000 Added 8.95%	48,700 $592,000
Q3 2021 Nov 12, 2021	SELL	$41.66 - $52.52 $41,660 - $52,520	-1,000 Reduced 2.19%	44,700 $2.16 Million
Q2 2021 Aug 13, 2021	BUY	$36.62 - $51.69 $18,310 - $25,845	500 Added 1.11%	45,700 $2.06 Million
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $605,113 - $871,852	-14,560 Reduced 24.36%	45,200 $2.18 Million
Q4 2020 Feb 05, 2021	SELL	$36.08 - $56.47 $214,315 - $335,431	-5,940 Reduced 9.04%	59,760 $3.22 Million
Q3 2020 Nov 06, 2020	SELL	$33.26 - $40.48 $758,328 - $922,943	-22,800 Reduced 25.76%	65,700 $2.42 Million
Q2 2020 Aug 13, 2020	BUY	$24.21 - $31.02 $689,985 - $884,070	28,500 Added 47.5%	88,500 $2.74 Million
Q1 2020 May 14, 2020	SELL	$20.5 - $34.53 $205,000 - $345,300	-10,000 Reduced 14.29%	60,000 $1.66 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $56,880 - $89,520	-3,000 Reduced 4.11%	70,000 $2.05 Million
Q3 2019 Nov 01, 2019	SELL	$19.12 - $26.24 $1.04 Million - $1.42 Million	-54,190 Reduced 42.61%	73,000 $1.4 Million
Q2 2019 Aug 02, 2019	SELL	$19.57 - $24.1 $105,912 - $130,429	-5,412 Reduced 4.08%	127,190 $2.79 Million
Q1 2019 May 02, 2019	SELL	$12.14 - $20.46 $145,947 - $245,970	-12,022 Reduced 8.31%	132,602 $2.71 Million
Q4 2018 Jan 30, 2019	SELL	$11.24 - $18.5 $2.08 Million - $3.42 Million	-185,113 Reduced 56.14%	144,624 $1.82 Million
Q3 2018 Nov 02, 2018	SELL	$12.5 - $15.38 $402,450 - $495,174	-32,196 Reduced 8.9%	329,737 $5.06 Million
Q2 2018 Aug 10, 2018	SELL	$7.99 - $14.05 $3.24 Million - $5.71 Million	-406,067 Reduced 52.87%	361,933 $4.75 Million
Q1 2018 May 09, 2018	BUY	$7.23 - $8.76 $2.11 Million - $2.55 Million	291,600 Added 61.21%	768,000 $6.27 Million
Q4 2017 Feb 02, 2018	BUY	$8.02 - $11.18 $893,428 - $1.25 Million	111,400 Added 30.52%	476,400 $4.22 Million
Q3 2017 Nov 01, 2017	BUY	$9.11 - $11.26 $3.33 Million - $4.11 Million	365,000	365,000 $4.06 Million

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.4B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Neogenomics Inc Transaction History